Los Angeles Capital Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,614
Closed -$340K 1459
2017
Q3
$340K Hold
11,614
﹤0.01% 1123
2017
Q2
$305K Buy
11,614
+100
+0.9% +$2.46K ﹤0.01% 1057
2017
Q1
$269K Buy
11,514
+1,300
+13% +$32.1K ﹤0.01% 1030
2016
Q4
$257K Sell
10,214
-10,300
-50% -$260K ﹤0.01% 1051
2016
Q3
$576K Sell
20,514
-125
-0.6% -$3.2K ﹤0.01% 865
2016
Q2
$509K Sell
20,639
-57,920
-74% -$1.44M ﹤0.01% 897
2016
Q1
$1.74M Sell
78,559
-11,310
-13% -$301K 0.02% 495
2015
Q4
$3.15M Hold
89,869
0.03% 418
2015
Q3
$2.56M Hold
89,869
0.02% 483
2015
Q2
$2.99M Sell
89,869
-2,550
-3% -$78.3K 0.03% 475
2015
Q1
$2.6M Sell
92,419
-8,240
-8% -$205K 0.02% 490
2014
Q4
$2.08M Buy
100,659
+13,220
+15% +$314K 0.02% 480
2014
Q3
$2.14M Buy
87,439
+71,641
+453% +$1.9M 0.03% 434
2014
Q2
$452K Sell
15,798
-14,135
-47% -$393K ﹤0.01% 912
2014
Q1
$838K Sell
29,933
-46,715
-61% -$1.15M 0.01% 721
2013
Q4
$1.65M Sell
76,648
-1,220
-2% -$22.2K 0.02% 537
2013
Q3
$1.03M Buy
77,868
+265
+0.3% +$3.57K 0.01% 660
2013
Q2
$1.08M Buy
+77,603
New +$1.1M 0.02% 635

Los Angeles Capital Management's PMC Position: Q4 2017 in Review

Los Angeles Capital Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 11,614 shares — an estimated $340K sold.

Los Angeles Capital Management first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $3.15M in Q4 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Los Angeles Capital Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Los Angeles Capital Management sold 11,614 PharMerica Corporation shares in Q4 2017, an estimated $340K.
  • Los Angeles Capital Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
  • Los Angeles Capital Management's PharMerica Corporation position peaked at $3.15M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Los Angeles Capital Management's 13F filing for Q4 2017, filed 5 Feb 2018.